News & Events
Category: Publications 7 October 2025
Advancing oncology drug development: Innovative approaches to enhance success rates while reducing animal testing
Authored by Hans Hendricks
Hendriks H. Advancing Oncology Drug Development: Innovative Approaches to Enhance Success Rates While Reducing Animal Testing. BBA Reviews on Cancer. Biochim Biophys Acta Rev Cancer 2025 Pages 189467. doi: 10.1016/j.bbcan.2025.189467. PMID: 41046061
Category: Events 13 June 2025
“From Target to Market” – The BBA Biotech Pharma Summer School
Date: 09 – 12 September 2025
Time: Daily 09.00 a.m. – 06.00 p.m.
Location: Gläsernes Labor, Building 13, Rooms 202, 203
Robert-Rössle-Str. 10, 13125 Berlin-Buch
Lecturers: Our trainers are experts in medicine, pharmaceutical industry, biotech companies, leaders of contract research institutes and consultants for clinical development. Among others, the following Cornelis members will take part as speakers:
- Wolf Stefan Richter
- Andreas Baumann
- Jens Hoffmann
- Michael Hildebrand
The modular course concept combines lectures with case-oriented, practical exercises on each level of the clinical development. Attendees get a comprehensive overview on the process of drug development in biotechnology as well as in the pharmaceutical industry – from the idea to market release.
Category: Press Releases 22 May 2025
Dear colleagues,
With disbelief, we have been receiving the sad news that our distinguished member Werner Skuballa passed away earlier this month. Werner was a founding member of CONELIS and also the inventor of our association's name. He actively contributed over many years to the development of our network and the interaction of all members in an outstanding manner. He was an extraordinary individual, a highly valued colleague, chemist, and scientist. We will miss him and will keep him in sincere memory.
Our deepest condolences are going to his wife and his family. Our thoughts are with them during these mournful days.
The Board for all members of Conelis e.V.
Category: Press Releases 12 December 2024
EPO End of Year Summary
Dear Colleagues,
As the year draws to a close, we extend our warmest holiday greetings and heartfelt thanks for trusting us to partner with you in accelerating your preclinical oncology drug development programs. This year has been a remarkable journey in advancements in preclinical oncology research. We've supported advancements across a spectrum of tumor types, treatment modalities, and in vivo / in vitro disease models.
We are also proud to announce the establishment of EPO-Oncodiscovery, our new U.S.-based site. This expansion strengthens our ability to connect with clients and partners across North America, attend key oncology conferences, and provide localized expertise in preclinical oncology drug development.
Key Highlights from our Newsletters in 2024:
Category: Events 5 June 2024
“Building the Bridge from Pre-Clinical to Clinical Studies” A Panel Discussion
with Jens Hoffmann and Michael Firgens (speakers)
June 13, 2024 from 5:00 – 6:30 p.m.
Category: Events 20 July 2023
QP Forum 2023
Michael Hildebrand will attend the Qualified Person Forum in Vienna, 12-13 October 2023.
Category: Events 20 July 2023
The GLA Biotech & Pharma Summer School
Michael Hildebrand and Wolf-Stefan Richter und Jens Hoffmann will present at “From Target to Market – The GLA Biotech & Pharma Summer School” from August 30 to September 2 in Berlin.
Category: Events 20 December 2022
Jens Hoffmann is a co-organizer of 21st International AEK Cancer Congress 2023
As speaker for the working group “New Therapies” in the German Cancer Research Organization (DKG/AEK), Jens Hoffmann is involved in the organization of the 21st International AEK Cancer Congress “Towards New Cancer Therapies: Mechanisms and Molecules” which will take place on February 15 - 17, 2023 at the Kongress Palais in Kassel (Germany).
Category: Events 2 December 2022
17th QP Forum
Pre-Conference Session IMPs PLUS Conference
Berlin 30.11.-02.12.2022
Category: Press Releases 29 November 2022
Sprachpate bei Kitakindern
Die "Berliner Zeitung" berichtet über Matthias Bräutigams ehrenamtliche Tätigkeit als Sprachpate für Berliner Kinder, die Sprachschwierigkeiten haben.
Was Sprachpaten mit Kitakindern erleben: „Er war wie in einer Schockstarre“